Fluocinonide NDC 71656-094

NDC codes

FDA NDC Directory

Product NDC (as listed)71656-094Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71656-0094Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71656-094-20	71656009420	20 mL in 1 BOTTLE (71656-094-20)Marketed from May 11, 2026
71656-094-60	71656009460	60 mL in 1 BOTTLE (71656-094-60)Marketed from May 11, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fluocinonide
Generic name (nonproprietary): fluocinonide
Active ingredients: Fluocinonide — .5 mg/mL
Dosage form: Solution
Route: Topical
Labeler: Saptalis Pharmaceuticals, LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207554
Marketing start: May 11, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 71656-094_518fd6ee-8b48-28ae-e063-6394a90a1303SPL ID 518fd6ee-8b48-28ae-e063-6394a90a1303SPL set ID 20f8e9a2-a63d-4bee-bc14-b9f04087d87bRxCUI 310364UNII 2W4A77YPAN
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471656009420 followed by a unit qualifier and the quantity

Package 71656-0094-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Fluocinonide Topical Solution USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)